These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 199477

  • 41. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
    Bagshawe KD, Lawler SD, Paradinas FJ, Dent J, Brown P, Boxer GM.
    Lancet; 1990 May 05; 335(8697):1074-6. PubMed ID: 1970378
    [Abstract] [Full Text] [Related]

  • 42. The significance of serum progesterone and serum unconjugated oestradiol-17beta in unaborted hydatidiform mole.
    Dawood MY.
    Acta Endocrinol (Copenh); 1975 Aug 05; 79(4):729-39. PubMed ID: 169657
    [Abstract] [Full Text] [Related]

  • 43. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun 05; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 44. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease.
    Osathanondh R, Berkowitz RS, de Cholnoky C, Smith BS, Goldstein DP, Tyson JE.
    J Reprod Med; 1986 Mar 05; 31(3):179-83. PubMed ID: 3009803
    [Abstract] [Full Text] [Related]

  • 45. A specific and sensitive sandwich enzyme immunoassay for human chorionic gonadotropin using antibodies against the carboxyl-terminal portion of the beta-subunit.
    Kondo K, Imagawa M, Iwasa S, Kitada C, Konishi E, Suzuki N, Yamoto M, Nakano R, Yoshitake S, Ishikawa E.
    Clin Chim Acta; 1984 Apr 13; 138(2):229-35. PubMed ID: 6327121
    [No Abstract] [Full Text] [Related]

  • 46. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 13; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 47. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ, Buck RH, Joubert SM.
    S Afr Med J; 1989 Apr 01; 75(7):318-9. PubMed ID: 2538933
    [Abstract] [Full Text] [Related]

  • 48. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec 01; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 49. [The biochemical aspects of trophoblastic disease].
    Massart C, Le Pogamp C.
    Arch Anat Cytol Pathol; 1983 Dec 01; 31(2):115-6. PubMed ID: 6309102
    [No Abstract] [Full Text] [Related]

  • 50. The management of patients with gestational trophoblastic neoplasia based on the antigenic properties of human chorionic gonadotropin.
    Goldstein DP, Nudemberg F, Lymeburner N, Levesque L, Shore C.
    J Surg Oncol; 1973 Dec 01; 5(1):1-8. PubMed ID: 4736212
    [No Abstract] [Full Text] [Related]

  • 51. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
    Than GN, Bohn H, Csaba IF, Szabó DG, Karg NJ, Göcze P.
    Arch Gynecol; 1981 Dec 01; 231(1):33-9. PubMed ID: 6174083
    [Abstract] [Full Text] [Related]

  • 52. Serum 17 alpha-hydroxyprogesterone in patients with gestational trophoblastic neoplasms.
    Osathanondh R, Goldstein DP, Tulchinsky D, Finn AE.
    Obstet Gynecol; 1977 Jan 01; 49(1):77-9. PubMed ID: 187990
    [Abstract] [Full Text] [Related]

  • 53. Comparative studies on biological, immunological and biochemical properties of various human chorionic gonadotropins in blood. 1.
    Tokura T.
    Acta Obstet Gynaecol Jpn; 1970 Jul 01; 17(3):186-97. PubMed ID: 5468865
    [No Abstract] [Full Text] [Related]

  • 54. [Composite microassays of plasma progesterone, 17alpha-OH-progestrerone, estrone, 17beta-estradiol and estriol in normal adult women. I. Assay methods and steroid patterns in normal menstrual cycle (author's transl)].
    Suginami H.
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov 20; 51(11):908-23. PubMed ID: 1241848
    [Abstract] [Full Text] [Related]

  • 55. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J, Rosenshein NB, Block BS.
    Gynecol Oncol; 1988 Jan 20; 29(1):82-6. PubMed ID: 2448190
    [Abstract] [Full Text] [Related]

  • 56. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
    Ho PC, Wong LC, Ma HK.
    Obstet Gynecol; 1986 Jan 20; 67(1):99-106. PubMed ID: 3940346
    [Abstract] [Full Text] [Related]

  • 57. Plasma hormone changes during infusions of prostaglandins F2alpha and E2 for therapeutic abortion.
    Newton J, Collins W.
    Adv Biosci; 1973 Jan 20; 9():689-99. PubMed ID: 4805881
    [No Abstract] [Full Text] [Related]

  • 58. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar 20; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 59. The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system.
    Rushworth AG, Orr AH, Bagshawe KD.
    Br J Cancer; 1968 Jun 20; 22(2):253-7. PubMed ID: 4298235
    [No Abstract] [Full Text] [Related]

  • 60. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN, Salem HT, Chard T, Huang SC, Ouyang PC.
    Br J Obstet Gynaecol; 1982 Jan 20; 89(1):69-72. PubMed ID: 6277363
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.